Details for New Drug Application (NDA): 211330
✉ Email this page to a colleague
The generic ingredient in GABAPENTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-eight suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 211330
Tradename: | GABAPENTIN |
Applicant: | Pai Holdings Pharm |
Ingredient: | gabapentin |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 250MG/5ML | ||||
Approval Date: | Dec 3, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription